Prevention of IUGR;Prévention du RCIU vasculaire

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 42, Issue 8, 2013, Pages 1008-1017

  Nizard, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aspirin; Intrauterine growth restriction; Pregnancy; Prevention

Indexed keywords

ARTICLE; BODY MASS; HUMAN; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; MATERNAL AGE; MATERNAL HYPERTENSION; PERINATAL PERIOD; PLACENTA DISORDER; PREECLAMPSIA; RISK FACTOR; SMOKING;

ASPIRIN; ASPIRINE; GROSSESSE; INTRAUTERINE GROWTH RESTRICTION; PREGNANCY; PREVENTION; PRÉVENTION; RETARD DE CROISSANCE INTRA-UTÉRIN;

BODY WEIGHT; CHRONIC DISEASE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; SMOKING;

EID: 84889043144     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2013.09.022     Document Type: Article

References (63)

1. A. Gaudineau Prévalence, facteurs de risque et morbi-mortalité materno-fœtale des troubles de la croissance fœtale J Gynecol Obstet Biol Reprod 42 2013 10.1016/j.jgyn.2013.09.013
2. L.J. Salomon, and V. Malan Bilan étiologique du retard de croissance intra-utérin (RCIU) J Gynecol Obstet Biol Reprod 42 2013 10.1016/j.jgyn.2013.09.016
3. Haute Autorité de santé Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. Recommandations professionnelles 2007 Haute Autorité de santé
4. J. Gardosi, and A. Francis Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles Am J Obstet Gynecol 201 2009 28 [e1-8]
5. X.K. Chen, S.W. Wen, N. Fleming, K. Demissie, G.G. Rhoads, and M. Walker Teenage pregnancy and adverse birth outcomes: a large population-based retrospective cohort study Int J Epidemiol 36 2007 368 373
6. W.M. Gilbert, T.S. Nesbitt, and B. Danielsen Childbearing beyond age 40: pregnancy outcome in 24,032 cases Obstet Gynecol 93 1999 9 14
7. P.S. Shah Knowledge Synthesis Group on Determinants of LBWPTb. Parity and low birth weight and preterm birth: a systematic review and meta-analyses Acta Obstet Gynecol Scand 89 2010 862 875
8. L.M.E. McCowan, G.A. Dekker, E. Chan, A. Stewart, L.C. Chappell, and M. Hunter Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study BMJ 338 2009 b1081-b
9. T.Y. Leung, T.N. Leung, D.S. Sahota, O.K. Chan, L.W. Chan, and T.Y. Fung Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women BJOG 115 2008 1529 1537
10. M.W. Pang, T.N. Leung, D.S. Sahota, T.K. Lau, and A.M. Chang Development of a customised birthweight standard for ethnic Chinese subjects Aust N Z J Obstet Gynaecol 40 2000 161 164
11. N.J. Sebire, M. Jolly, J.P. Harris, J. Wadsworth, M. Joffe, and R.W. Beard Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London Int J Obes Relat Metab Disord 25 2001 1175 1182
12. J. Gardosi, V. Madurasinghe, M. Williams, A. Malik, and A. Francis Maternal and fetal risk factors for stillbirth: population-based study BMJ 346 2013 f108
13. N.J. Sebire, M. Jolly, J. Harris, L. Regan, and S. Robinson Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London BJOG 108 2001 61 66
14. K.M. Rasmussen, and A.L. Yaktine Determining optimal weight gain Weight gain during pregnancy: reexamining the guidelines 2009 The National Academies Press Washington, D.C 241 262
15. K.B. Filion, H.A. Abenhaim, S. Mottillo, L. Joseph, A. Gervais, and J. O'Loughlin The effect of smoking cessation counselling in pregnant women: a meta-analysis of randomised controlled trials BJOG 118 2011 1422 1428
16. M.E. Clowse, L.S. Magder, F. Witter, and M. Petri The impact of increased lupus activity on obstetric outcomes Arthritis Rheum 52 2005 514 521
17. M. Petri, D. Howard, and J. Repke Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience Arthritis Rheum 34 1991 1538 1545
18. E. Imbasciati, A. Tincani, G. Gregorini, A. Doria, G. Moroni, and G. Cabiddu Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome Nephrol Dial Transplant 24 2009 519 525
19. E.C. Jensen, B.W. Gallaher, B.H. Breier, and J.E. Harding The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep J Endocrinol 174 2002 27 36
20. K.E. Murphy, M.E. Hannah, A.R. Willan, S.A. Hewson, A. Ohlsson, and E.N. Kelly Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial Lancet 372 2008 2143 2151
21. J.L. Nugent, M. Wareing, V. Palin, C.P. Sibley, P.N. Baker, and D.W. Ray Chronic glucocorticoid exposure potentiates placental chorionic plate artery constriction: implications for aberrant fetoplacental vascular resistance in fetal growth restriction Endocrinology 154 2013 876 887
22. G.K. Bertsias, M. Tektonidou, Z. Amoura, M. Aringer, I. Bajema, and J.H. Berden Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis Ann Rheum Dis 71 2012 1771 1782
23. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
24. M. Yasuda, K. Takakuwa, A. Tokunaga, and K. Tanaka Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy Obstet Gynecol 86 1995 555 559
25. K. Abou-Nassar, M. Carrier, T. Ramsay, and M.A. Rodger The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis Thromb Res 128 2011 77 85
26. S.V. Glinianaia, P.W. Tennant, R.W. Bilous, J. Rankin, and R. Bell HbA(1c) and birthweight in women with preconception type 1 and type 2 diabetes: a population-based cohort study Diabetologia 55 2012 3193 3203
27. M. Gordon, M.B. Landon, P. Samuels, S. Hissrich, and S.G. Gabbe Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy Obstet Gynecol 87 1996 401 409
28. I.F. Nevis, A. Reitsma, A. Dominic, S. McDonald, L. Thabane, and E.A. Akl Pregnancy outcomes in women with chronic kidney disease: a systematic review Clin J Am Soc Nephrol 6 2011 2587 2598
29. M.J. Fischer, S.D. Lehnerz, J.R. Hebert, and C.R. Parikh Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy Am J Kidney Dis 43 2004 415 423
30. S.D. McDonald, Z. Han, S. Mulla, O. Lutsiv, T. Lee, and J. Beyene High gestational weight gain and the risk of preterm birth and low birth weight: a systematic review and meta-analysis J Obstet Gynaecol Can 33 2011 1223 1233
31. S. Thangaratinam, E. Rogozinska, K. Jolly, S. Glinkowski, T. Roseboom, and J.W. Tomlinson Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence BMJ 344 2012 e2088 e2090
32. A. Beyerlein, B. Schiessl, N. Lack, and R. von Kries Associations of gestational weight loss with birth-related outcome: a retrospective cohort study BJOG 118 2011 55 61
33. M.-V. Senat, and V. Tsatsaris Surveillance anténatale, prise en charge et indications de naissance en cas de RCIU vasculaire isolé J Gynecol Obstet Biol Reprod 42 2013 10.1016/j.jgyn.2013.09.017
34. B.A. Haider, I. Olofin, M. Wang, D. Spiegelman, M. Ezzati, and W.W. Fawzi Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis BMJ 346 2013 f3443
35. J.P. Peña-Rosas, L.M. De-Regil, T. Dowswell, and F.E. Viteri Daily oral iron supplementation during pregnancy Cochrane Database Syst Rev 12 2012 CD004736
36. J.F. Stratton, S.N. Scanaill, B. Stuart, and M.J. Turner Are babies of normal birth weight who fail to reach their growth potential as diagnosed by ultrasound at increased risk? Ultrasound Obstet Gynecol 5 1995 114 118
37. O. Langer, J. Levy, L. Brustman, A. Anyaegbunam, R. Merkatz, and M. Divon Glycemic control in gestational diabetes mellitus: how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 161 1989 646 653
38. B. Haddad, and B.M. Sibai Chronic hypertension in pregnancy Ann Med 31 1999 246 252
39. P. von Dadelszen, M.P. Ornstein, S.B. Bull, A.G. Logan, G. Koren, and L.A. Magee Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis Lancet 355 2000 87 92
40. L. Butters, S. Kennedy, and P.C. Rubin Atenolol in essential hypertension during pregnancy BMJ 301 1990 587 589
41. L.A. Magee, E. Elran, S.B. Bull, A. Logan, and G. Koren Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials Eur J Obstet Gynecol Reprod Biol 88 2000 15 26
42. V. Regitz-Zagrosek, and C. Blomstrom Lundqvist ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J 32 2011 3147 3197
43. W.J. Polzin, J.N. Kopelman, R.D. Robinson, J.A. Read, and K. Brady The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction Obstet Gynecol 78 1991 1108 1111
44. K.E. Sletnes, F. Wisloff, N. Moe, and P.O. Dale Antiphospholipid antibodies in preeclamptic women: relation to growth retardation and neonatal outcome Acta Obstet Gynecol Scand 71 1992 112 117
45. S.M. Bates, I.A. Greer, S. Middeldorp, D.L. Veenstra, A.M. Prabulos, and P.O. Vandvik VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e691S 736S
46. M. Haase, S. Morgera, C. Bamberg, H. Halle, S. Martini, and B. Hocher A systematic approach to managing pregnant dialysis patients: the importance of an intensified haemodiafiltration protocol Nephrol Dial Transplant 20 2005 2537 2542
47. O. Moranne, V. Samouelian, F. Lapeyre, D. Pagniez, D. Subtil, and P. Dequiedt [Pregnancy and hemodialysis] Nephrologie 25 2004 287 292
48. L. Duley, D.J. Henderson-Smart, S. Meher, and J.F. King Antiplatelet agents for preventing preeclampsia and its complications Cochrane Database Syst Rev 2007 CD004659
49. L.M. Askie, L. Duley, D.J. Henderson-Smart, L.A. Stewart, and P.C. Group Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data Lancet 369 2007 1791 1798
50. E. Bujold, S. Roberge, Y. Lacasse, M. Bureau, F. Audibert, and S. Marcoux Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis Obstet Gynecol 116 2010 402 414
51. D.E. Ayala, R. Ucieda, and R.C. Hermida Chronotherapy with low-dose aspirin for prevention of complications in pregnancy Chronobiol Int 30 2013 260 279
52. D. Subtil Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2) BJOG 110 2003 485 491
53. M. Vainio, E. Kujansuu, M. Iso-Mustajarvi, and J. Maenpaa Low-dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches BJOG 109 2002 161 167
54. E. Scazzocchio, F. Figueras, F. Crispi, E. Meler, N. Masoller, and R. Mula Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting Am J Obstet Gynecol 208 2013 203 [e1-10]
55. L.C. Poon, A. Syngelaki, R. Akolekar, J. Lai, and K.H. Nicolaides Combined screening for preeclampsia and small for gestational age at 11-13 weeks Fetal Diagn Ther 33 2013 16 27
56. L.M. De-Regil, C. Palacios, A. Ansary, R. Kulier, and J.P. Peña-Rosas Vitamin D supplementation for women during pregnancy Cochrane Database Syst Rev 2 2012 CD008873
57. G.J. Hofmeyr, T.A. Lawrie, A.N. Atallah, and L. Duley Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems Cochrane Database Syst Rev 8 2010 CD001059
58. R. Mori, E. Ota, P. Middleton, R. Tobe-Gai, K. Mahomed, and Z. Bhutta Zinc supplementation for improving pregnancy and infant outcome Cochrane Database Syst Rev 7 2012 CD000230
59. M. Makrides, and C.A. Crowther Magnesium supplementation in pregnancy Cochrane Database Syst Rev 4 2001 CD000937
60. E. Ota, R. Tobe-Gai, R. Mori, and D. Farrar Antenatal dietary advice and supplementation to increase energy and protein intake Cochrane Database Syst Rev 9 2012 CD000032
61. F. Facco, W. You, and W. Grobman Genetic thrombophilias and intrauterine growth restriction: a meta-analysis Obstet Gynecol 113 2009 1206 1216
62. B.P. Zhu, R.T. Rolfs, B.E. Nangle, and J.M. Horan Effect of the interval between pregnancies on perinatal outcomes N Engl J Med 340 1999 589 594
63. Pottecher Y, Luton D, Zupan V, Collet M. Prise en charge multidisciplinaire des formes graves de pré-éclampsie 2009. http://www.sfar.org/-docs/articles/105-rfe-preeclampsie.pdf. [Accédé le 09/09/2013].